Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.040
+0.070 (2.36%)
At close: Jul 30, 2026, 4:00 PM EDT
3.040
0.00 (0.00%)
Pre-market: Jul 31, 2026, 7:47 AM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $1.61 billion as of July 31, 2026. Its market cap has decreased by -37.52% in one year.
Market Cap
1.61B
Enterprise Value
1.03B
1-Year Change
-37.52%
Ranking
Category
Stock Price
$3.04
ChartMarket Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $1.61B, a decrease of -68.21%. That is a compound annual growth rate of -19.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 1.61B | -24.20% |
| Dec 31, 2025 | 2.13B | -20.16% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.71B |
| Generate Biomedicines | 1.67B |
| Ascentage Pharma Group International | 1.65B |
| AbCellera Biologics | 1.64B |
| Sarepta Therapeutics | 1.64B |
| Zymeworks | 1.63B |
| Innoviva | 1.61B |
| Maze Therapeutics | 1.55B |